Program Information
Preclinical Radioimmunogenomics Study to Design Personalized Radiotherapy
H Abdollahi1*, (1) Iran University of Medical Sciences, Tehran, Iran, Tehran, Tehran
Presentations
SU-F-R-1 (Sunday, July 31, 2016) 3:00 PM - 6:00 PM Room: Exhibit Hall
Purpose:
Radiogenomics is an active area of research to find clinical correlation between genomics and radiotherapy outcomes. In this era, many different biological issues should be taken into account. In this study we aimed to introduce "Radioimmunogenomics" as a new approach to study immunogetics issue regard to radiotherapy induced clinical manifestations.
Methods:
We studied different immunological pathways and signaling molecules which underling radiation response of normal and malignant tissues. In the other hand, we found many genes and proteins are responsible to radiation effects on biological tissues. We defined a theoretical framework to correlate these genes with radiotherapy outcomes as TCP and NTCP biological dose tools.
Results:
Our theoretical results showed, high-throughput immunogenomics biomarkers can be correlated with radiotherapy outcomes. Genes regarding to inflammation, apoptosis, repair molecules and many other immunological markers can be defined as radioimmune markers to predict radiotherapy response.
Conclusion:
Radioimmunogenomics can be used as a new personalized radiotherapy research area to enhance treatment outcome as well as quality of life.
Contact Email: